Related Experiment Videos
[The pathogenesis of chronic Chagas' myocarditis: the role of autoimmune and microvascular factors]
1Departamento de Patologia, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Brasil.
Insights
Chronic Chagasic myocarditis pathogenesis involves progressive cell death, fibrosis, and hypertrophy. Autoimmune factors and microcirculation changes may drive these processes, suggesting new therapeutic targets.
Area of Science:
- Cardiology
- Immunology
- Infectious Diseases
Context:
- The exact mechanisms driving chronic Chagasic myocarditis are not fully understood.
- Existing hypotheses include direct parasite damage, neurogenic effects, autoimmunity, and microvascular issues.
Purpose:
- To propose a dynamic, alternative hypothesis for the pathogenesis of chronic Chagasic myocarditis.
- To highlight the roles of progressive focal cellular necrosis, fibrosis, and hypertrophy.
Summary:
- This study posits that Chagasic myocarditis develops through cumulative focal cellular necrosis.
- Associated reactive fibrosis and myocyte hypertrophy are key features.
- Autoimmune factors and altered myocardial microcirculation are proposed as initiators and perpetuators.
Impact:
- The proposed hypothesis may guide future therapeutic strategies for chronic Chagasic patients.
- Optimizing medical treatment could potentially improve patient prognosis.
Abstract:
The pathogenesis of chronic chagasic myocarditis remains incompletely understood. Several hypotheses have been proposed: (1) direct tissue destruction by Trypanosoma cruzi; (2) neurogenic theory; (3) anti-heart immune reactions; and (4) microvascular disease. We present herein a dynamic alternative hypothesis. We believe that the development of myocarditis is related to progressive and additive focal cellular necrosis, and associated reactive and reparative myocardial fibrosis and surrounding myocytes hypertrophy. These processes may be initiated and perpetuated by autoimmune factors and alterations in the myocardial microcirculation. This could imply future therapeutic strategies in the management of chronic chagasic patients to optimize the medical treatment and hopefully improve the prognosis.